• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFECELL STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 16, FIRM; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFECELL STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 16, FIRM; MESH, SURGICAL Back to Search Results
Catalog Number 1016002
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Adhesion(s) (1695); Hernia (2240); Obstruction/Occlusion (2422); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 10/10/2018
Type of Reportable Event Serious Injury
Event or Problem Description
Limited information was reported through a legal event that a patient was implanted with strattice firm on (b)(6) 2016.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.
 
Additional Manufacturer Narrative
The lot associated with this event was not reported and remains unknown; therefore a review into the device history records could not be performed.No strattice devices were returned for evaluation.Based on the limited information, and without relevant patient factors, a relationship between the event and the strattice could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
A review of the device history record for strattice lot sp100392 has been completed.No deviations or non-conformances noted.This is a known potential adverse event addressed in the product labeling.Without relevant patient factors, a relationship between the strattice and this event could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Event or Problem Description
This is follow up#1 to report on 28/mar/2025, pmqa received notification from legal that the plaintiff profile form (ppf).As per the ppf form, the patient underwent recurrent incarcerated incisional hernia surgery and was implanted with the strattice device lot# sp100392-141 and ref.#(b)(4) on (b)(6) 2016.On (b)(6) 2018, patient underwent small-bowel resection, primary anastomosis, extensive lysis of adhesions, removal of prior mesh and repair of recurrent incarcerated incisional hernia with a non-abbive device, phasix mesh (lot #huby1146).The form lists the condition that was treated: (b)(6) 2016 - reduction and repair (strattice) of incisional hernia with small bowel repair and extensive lysis of adhesions.(b)(6) 2018 - abdominal pain, evaluation of sbo; ct ab/pel scan-small bowel obstruction secondary to ventral hernia containing both small and large bowel.(b)(6) 2018 - abdominal pain; small-bowel resection, primary anastomosis, extensive lysis of adhesions, removal of prior mesh and phasix mesh repair of recurrent incarcerated incisional hernia.On (b)(6) 2014, patient was implanted with a non-abbvie device, ventralight st, lot #huyb0394.On (b)(6) 2016, ventralight st mesh was revised and subsequently removed on 11/oct/2018.Between 2016-2019 - hernia repair and small bowel surgeries, post-ops.7/aug/2024 - abdominal pain; cramping.As reported in the initial: limited information was reported through a legal event that a patient was implanted with strattice firm on (b)(6) 2016.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 16, FIRM
Common Device Name
MESH, SURGICAL
Manufacturer (Section D)
LIFECELL
one millennium way
branchburg NJ 08876
Manufacturer (Section G)
LIFECELL
one millennium way
branchburg NJ 08876
Manufacturer Contact
terry ingram
1 millennium way
branchburg, NJ 08876
8479366324
MDR Report Key21345558
Report Number1000306051-2025-00019
Device Sequence Number7853758
Product Code FTM
UDI-Device Identifier00818410010119
UDI-Public(01)00818410010119(10)SP100392(11)160517(17)180430
Combination Product (Y/N)N
PMA/510(K) Number
K070560
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/21/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2018
Device Catalogue Number1016002
Device Lot NumberSP100392
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/14/2025
Supplement Date Received by Manufacturer03/28/2025
Initial Report FDA Received Date02/10/2025
Supplement Report FDA Received Date04/21/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/17/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
Patient SexFemale
-
-